| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 09/13/2000 | EP1035202A2 A cloning method for DNA fragments using arbitrarily primed PCR |
| 09/13/2000 | EP1035133A2 Fusion proteins comprising carriers that can induce a dual immune response |
| 09/13/2000 | EP1035132A1 Monoclonal antibody inducing apoptosis |
| 09/13/2000 | EP1034785A2 Hepatitis C virus diagnostics and vaccines |
| 09/13/2000 | EP1034431A2 Method of detecting prostate specific antigen activation peptide |
| 09/13/2000 | EP1034299A1 Method for suppressing multiple drug resistance in cancer cells |
| 09/13/2000 | EP1034298A1 Humanization of murine antibody |
| 09/13/2000 | EP1034296A1 ribH POLYPEPTIDES AND POLYNUCLEOTIDES |
| 09/13/2000 | EP1034295A1 ribA |
| 09/13/2000 | EP1034292A2 Cell-specific retroviral vectors with antibody domains and method for the production thereof for selective gene transfer |
| 09/13/2000 | EP1034291A2 Pseudo-type retroviral vectors with modifiable surface capsid proteins |
| 09/13/2000 | EP1034277A2 EXTRACELLULAR MATRIX-BINDING PROTEINS FROM $i(STAPHYLOCOCCUS AUREUS) |
| 09/13/2000 | EP1034276A1 Novel era |
| 09/13/2000 | EP1034270A1 Compositions and methods of use of het |
| 09/13/2000 | EP1034268A1 G-protein coupled receptors and uses therefor |
| 09/13/2000 | EP1034265A1 Human cdc10 homolog |
| 09/13/2000 | EP1034264A1 Splice variants for human 5-ht 4? serotonin receptor and their applications, in particular for screening |
| 09/13/2000 | EP1034258A2 Nucleic acid transfer vector for the introduction of nucleic acid into the dna of a cell |
| 09/13/2000 | EP1034256A1 Anticoagulant test |
| 09/13/2000 | EP1034255A1 Lineage restricted glial precursors from the central nervous system |
| 09/13/2000 | EP1034187A1 $i(IN VITRO) AND $i(IN VIVO) GROWTH-PROMOTING PROTEINS AND PEPTIDES FOR KIDNEY EPITHELIAL CELLS |
| 09/13/2000 | EP1034186A2 Synthetic peptides containing citrulline recognized by rheumatoid arthritis sera as tools for diagnosis and treatment |
| 09/13/2000 | EP1034004A1 Recombinant mycoplasma hyopneumoniae vaccine |
| 09/13/2000 | EP1034003A1 Methods for treatment of hiv or other infections using a t cell or viral activator and anti-retroviral combination therapy |
| 09/13/2000 | EP1034002A1 Method for inhibiting premature rupture of fetal membranes, ripening of uterine cervix and preterm labor |
| 09/13/2000 | EP1034001A1 Cd154 blockade therapy for therapeutic protein inhibitor syndrome |
| 09/13/2000 | EP1034000A1 Method for obtaining vaccines for preventing the pathogenic effects related to a retroviral infection |
| 09/13/2000 | EP1033996A1 Prevention and treatment of amyloidogenic disease |
| 09/13/2000 | EP0938557B1 Methods and compositions for inhibiting inflammation and angiogenesis comprising a mammalian cd97 alpha subunit |
| 09/13/2000 | EP0814834B1 Non-toxic immunogens derived from a retroviral regulatory protein, antibodies directed against said immunogens, preparation method therefor, and pharmaceutical compositions containing the same |
| 09/13/2000 | EP0641439B1 Reagents and methods for the quantification of imipramine or desipramine in biological fluids |
| 09/13/2000 | EP0599935B1 Reagents and methods for the quantification of amitriptyline or nortriptyline in biological fluids |
| 09/12/2000 | USRE36866 Anti-aids immunotoxins |
| 09/12/2000 | US6118044 Transgenic animal allergy models and methods for their use |
| 09/12/2000 | US6117991 Plasmid pav2-htsh-beta on deposit as atcc 75505; for recombinant production, diagnosis and therapy of human thyroid cancer; anticarcinogenic agents |
| 09/12/2000 | US6117989 Human calcium-binding proteins |
| 09/12/2000 | US6117985 Negative selection process for enriching and recovering non-hematopoietic cells by reacting sample with antibodies which bind glycophorin a, cd2, cd14, cd16, cd38, cd45 and cd66b; removing bound cells; recovering tumor cells |
| 09/12/2000 | US6117982 Microbead coupled with binding molecules which lack fc portions and are specific for cd2, cd3 or other t cell receptor-linked components, cd4, cd5 or cd8; anticarcinogenic agents and treatment of infections |
| 09/12/2000 | US6117981 Hybridomas for lung cancer marker and monoclonal antibodies thereof |
| 09/12/2000 | US6117980 Humanized anti-IL-8 monoclonal antibodies |
| 09/12/2000 | US6117978 Protein having at least 63% identity to human protein having defined amino acid sequence; for diagnosis and therapy of alzheimer's disease; drug screening |
| 09/12/2000 | US6117839 For increasing bone growth in mammals |
| 09/12/2000 | US6117836 Glycosylation-mediated inhibition of factor X |
| 09/12/2000 | US6117679 Adjusting polynucleotide sequences; amplifying nucleotide sequences and screening a recombinant polynucleotide for a desired property |
| 09/12/2000 | US6117673 Nucleotide sequence which codes for a protein associated signal tranduction; for diagnosis, treatment and preventing defects associated with signal transduction |
| 09/12/2000 | US6117662 Respiratory nitrate reductase alpha subunit |
| 09/12/2000 | US6117656 Cloned genes encoding IG-CD4 fusion proteins and the use thereof |
| 09/12/2000 | US6117655 Nucleic acid encoding adhesion variants |
| 09/12/2000 | US6117654 Nucleotide sequence coding antiinflammatroy proteins; antiarthritic agents; antiinflammatory agents; bronchodilator agents |
| 09/12/2000 | US6117652 Production of proteins by cell culture |
| 09/12/2000 | US6117641 Assays and reagents for identifying anti-fungal agents and uses related thereto |
| 09/12/2000 | US6117631 Screening for immunogens; immobilizing an immunogen to a solid support, incubation in solution with antibodies, incubation with immunodendrimer, screen for bound immunodendrimer |
| 09/12/2000 | US6117445 Administration of an a1 adenosine receptor antagonist, or p2x purinoceptor or a compination of both offer potential as an antifibrotic or antisclerotic treatment |
| 09/12/2000 | US6117427 Administering immunogenic protein-alkaloid conjugate having indolo(4,3-fg)quinoline derivative |
| 09/12/2000 | US6117426 Human amine transporter polypeptide fragments |
| 09/12/2000 | US6117423 Highly purified species of human leukocyte interferon |
| 09/12/2000 | US6117421 Method for promoting cell growth and immunosuppression using chaperonin |
| 09/12/2000 | CA1341097C Factor viii binding domain of von willebrand factor |
| 09/08/2000 | WO2000052478A1 Detection of mtoc disrupting substances |
| 09/08/2000 | WO2000052477A1 Method and in vitro kit for selecting a drug for chemotherapy |
| 09/08/2000 | WO2000052475A1 Method for evaluating the intensity of muscular proteolysis |
| 09/08/2000 | WO2000052467A1 Methods of determining altered ndpk functions |
| 09/08/2000 | WO2000052056A2 Anti-plasmodium compositions and methods of use |
| 09/08/2000 | WO2000052055A1 SPECIFIC EGG YOLK ANTIBODIES IgY, THE OBTAINMENT AND USE THEREOF |
| 09/08/2000 | WO2000052054A2 Antibodies for cancer therapy and diagnosis |
| 09/08/2000 | WO2000052053A1 Antibodies against phosphomannan that are protective against candidiasis |
| 09/08/2000 | WO2000052041A1 Synthetic peptides containing protective epitopes for the treatment and prevention of periodontitis associated with porphyromonas gingivalis |
| 09/08/2000 | WO2000052028A1 TUMOR NECROSIS FACTOR RECEPTORS 6α and 6$g(b) |
| 09/08/2000 | WO2000052023A1 Method for the detection of congenital nephrotic syndrome |
| 09/08/2000 | WO2000052022A1 Secreted proteins and nucleic acids encoding them |
| 09/08/2000 | WO2000051637A1 ANTI-TNFα ANTIBODIES IN THERAPY OF ASTHMA |
| 09/08/2000 | WO2000051630A2 Methods for improving graft acceptance in a recipient by administration of a cytokine profile altering agent |
| 09/08/2000 | WO2000051628A2 Methods of modulating lipid metabolism and storage |
| 09/08/2000 | WO2000029583A3 Immunoglobulin superfamily proteins |
| 09/08/2000 | WO2000023573A3 Cd20-specific redirected t cells and their use in cellular immunotherapy of cd20+ malignancies |
| 09/08/2000 | WO2000019206A9 Ykl-40 as a marker and prognostic indicator for cancers |
| 09/08/2000 | WO2000018212A9 Platelet-derived growth factor c, dna coding therefor, and uses thereof |
| 09/08/2000 | WO2000012702A3 Human genes differentially expressed in colorectal cancer |
| 09/08/2000 | WO2000009709A3 Proteases and associated proteins |
| 09/08/2000 | WO1999049019A8 Luciferases, fluorescent proteins, nucleic acids encoding the luciferases and fluorescent proteins and the use thereof in diagnostics |
| 09/08/2000 | CA2742153A1 Method for radiolabeling a chelator-conjugated antibody with 111ln |
| 09/08/2000 | CA2368976A1 Method and in vitro kit for selecting a drug for chemotherapy |
| 09/08/2000 | CA2364279A1 Methods for improving graft acceptance in a recipient by administration of a cytokine profile altering agent |
| 09/08/2000 | CA2363498A1 Method for evaluating the intensity of muscular proteolysis |
| 09/08/2000 | CA2362924A1 Secreted proteins and nucleic acids encoding them |
| 09/08/2000 | CA2362840A1 Antibodies against phosphomannan that are protective against candidiasis |
| 09/08/2000 | CA2362477A1 Anti-plasmodium compositions and methods of use |
| 09/08/2000 | CA2361877A1 Antibodies for cancer therapy and diagnosis |
| 09/08/2000 | CA2327260A1 Methods of modulating lipid metabolism and storage |
| 09/06/2000 | EP1033574A2 Morphogenic protein screening method |
| 09/06/2000 | EP1033406A1 Inducer for production of antigen-specific antibody, expression vector containing gene therefor, and method of inducing production of antigen-specific antibody |
| 09/06/2000 | EP1033404A1 New gene with down-regulated expression in metastatic human melanoma cells |
| 09/06/2000 | EP1033401A2 Expressed sequence tags and encoded human proteins |
| 09/06/2000 | EP1033136A1 The process of preparing immunoglobulin for intravenous injection by viruses double-sterilized without adding any protectant |
| 09/06/2000 | EP1033135A1 Broadly reactive opsonic antibodies that react with common staphyloccoccal antigens |
| 09/06/2000 | EP1033134A1 Compositions inhibiting smooth muscle proliferation, method for the diagnosis of arteriosclerosis, and kits therefor |
| 09/06/2000 | EP1032838A1 125 human secreted proteins |
| 09/06/2000 | EP1032825A1 Improvements in or relating to electrochemical assays |
| 09/06/2000 | EP1032706A1 Reagents and methods useful for detecting diseases of the breast |
| 09/06/2000 | EP1032690A1 Stress resistance gene |